» Authors » Fiona N Conway

Fiona N Conway

Explore the profile of Fiona N Conway including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 100
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Espinosa A, Ruglass L, Conway F, Pattanshetti S, Ostroff J, Sheffer C
J Racial Ethn Health Disparities . 2025 Mar; PMID: 40053216
Hispanic and Non-Hispanic (NH) Black adults, particularly men, disproportionately experience significant smoking-related health disparities, including cancer. Thus, identifying factors that explicate sex, racial, and ethnic differences in cigarette use is...
2.
Dosanjh L, Lauby S, Fuentes J, Castro Y, Conway F, Conway F, et al.
Neurosci Biobehav Rev . 2025 Feb; 171:106062. PMID: 39952339
Adults with symptoms of anxiety, depression, or PTSD and a history of adverse childhood experiences (ACEs) may experience more severe symptoms than those without ACEs. The identification of mechanisms linking...
3.
Conway F, Kane H, Bingaman A, Kennedy P, Tang E, Patel S, et al.
Subst Use Addctn J . 2024 Aug; 46(2):256-265. PMID: 39087448
Background: Addressing the negative impact of substance use disorders (SUDs) on individuals, families, and communities is a public health priority. Most treatments and interventions require engagement with a healthcare provider...
4.
Conway F, Espinosa A, Ruglass L, Alexander W, Sheffer C
J Stud Alcohol Drugs . 2024 Jun; 85(6):856-866. PMID: 38837913
Objective: Black individuals are disproportionately affected by tobacco-related illnesses. Although tobacco use is often initiated in adolescence and risk factors thereof originate from multiple domains of influence, investigations of tobacco...
5.
Conway F, Kane H, Dorsainvil M, Kennedy P, Cance J
PLoS One . 2024 Jan; 19(1):e0296278. PMID: 38295049
Background: Experiencing drug cravings is an aspect of substance use disorders that frequently compromises the recovery efforts of people who use drugs. Most treatment approaches that address drug cravings either...
6.
Samora J, Jeong H, Conway F, Claborn K
J Stud Alcohol Drugs . 2024 Jan; 85(2):158-167. PMID: 38206672
Objective: This study aims to review applications of immersive, head-mounted display (HMD)-delivered virtual reality (VR) technology for the assessment and modification of clinically relevant factors (e.g., craving, electrophysiological reactions, brain...
7.
Espinosa A, Ruglass L, Conway F
J Subst Use Addict Treat . 2023 Sep; 153:208963. PMID: 37654011
Introduction: Racial/ethnic discrimination and ethnic identity, the affiliation and connection to one's ethnic group, are important for understanding alcohol, tobacco, and drug use disorders (AUD, TUD, DUD, respectively) among Hispanic/Latin...
8.
Claborn K, Samora J, McCormick K, Whittfield Q, Courtois F, Lozada K, et al.
Harm Reduct J . 2023 Jun; 20(1):70. PMID: 37296459
Background: Unprecedented increases in substance-related overdose fatalities have been observed in Texas and the U.S. since the onset of the COVID-19 pandemic and have made clear there is considerable need...
9.
Espinosa A, Conway F, Ruglass L, Sheffer C
Tob Induc Dis . 2023 May; 21:54. PMID: 37153727
Introduction: Tobacco use remains a primary cause of health disparities between Black and White Americans. Current approaches have not improved tobacco-related racial health disparities. This study aimed to identify differences...
10.
Claborn K, Cance J, Kane H, Hairgrove S, Conway F
Subst Use Misuse . 2023 Mar; 58(6):828-831. PMID: 36943062
Drug overdose deaths in Texas have been accelerating in recent years with an increase of 33% in the 12 months leading up to December 2020. Accurate counts of nonfatal overdoses...